Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation

Journal of Neurochemistry

Volumn 86, Issue 2, 2003, Pages 470-478

  Hu, William ^a,b   Gray, Noah W ^b   Brimijoin, Stephen ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Lysosomes; Muscarinic receptors; Pinocytosis; Protein turnover

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; FLUORESCENT DYE; MEMBRANE PROTEIN;

ACIDIFICATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LABELING; CELL POPULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME DEGRADATION; FUNCTIONAL MORPHOLOGY; IMMUNOCYTOCHEMISTRY; LYSOSOME; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; CELL ADHESION; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SPACE; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR FLUID; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; MACROLIDES; MICE; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, MUSCARINIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037817311     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01855.x     Document Type: Article

References (49)

1. Alvarez A. et al. (1998) Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18, 3213-3223.
2. Arendt T., Bruckner M. K., Lange M. and Bigl V. (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21, 381-396.
3. Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G. and Fairbaim A. (1983) Molecular forms of acetyl-cholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
4. Atack J. R., May C., Kaye J. A., Kay A. D. and Rapoport S. I. (1988) Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann. Neurol. 23, 161-167.
5. Bahr B. A. and Bendiske J. (2002) The neuropathogenic contributions of lysosomal dysfunction. J. Neurochem. 83, 481-489.
6. Bahr B. A., Hoffman K., Yang A. J., Hess U., Glabe C. G. and Lynch G. (1998) Amyloid beta protein is intemalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397, 139-147.
7. Berdnar I. et al. (2002) Selective nicotinic receptor consequences in APP-Swe transgenic mice. Mol. Cell. Neurosci. 20, 354-365.
8. Brimijoin S., Rakonczay Z. and Hammond P. (1987) Immunoassay of acetylcholinesterase. Fed. Proc. 46, 2557-2562.
9. Bronfman F. C., Moechars D. and Van Leuven F. (2000) Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol. Dis. 7, 152-168.
10. Busciglio J., Lorenzo A. and Yankner B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
11. Cataldo A. M., Hamilton D. J. and Nixon R. A. (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640, 68-80.
12. Cataldo A. M., Bamett J. L., Pieroni C. and Nixon R. A. (1997) Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17, 6142-6151.
13. Ditaranto K., Tekirian T. L. and Yang A. J. (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8, 19-31.
14. Ellman G., Courtney K., Andres V. and Featherstone R. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
15. Estus S. et al. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
16. Geula C. and Mesulam M.-M. (1989) Special properties of cholinesterases in the crebral cortex of Alzheimer's disease. Brain Res. 498, 185-189.
17. Glenner G. G. and Wong C. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
18. Golde T. E., Estus S., Younkin L. H., Selkoe D. J. and Younkin S. G. (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730.
19. Hammond P. and Brimijoin S. (1988) Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions. J. Neurochem. 50, 1111-1116.
20. Homewood C., Warhurst D., Peters W. and Baggaley V. (1972) Lysosomes, pH and the anti-malarial action of chloroquine. Nature 235, 50-52.
21. Hooper N. M., Karran E. H. and Tumer A. J. (1997) Membrane protein secretases. Biochem. J. 321, 265-279.
22. Hsiao K. K. et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218.
23. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F. and Cole G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
24. Inestrosa N. C., Alvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C., Casanueva O. I., Soto C. and Garrido J. (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
25. Ji Z. S., Miranda R. D., Newhouse Y. M., Weisgraber K. H., Huang Y. and Mahley R. W. (2002) Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 277, 21821-21828.
26. Johnson C. and Russell R. (1975) A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64, 229-238.
27. Koenigsberger C., Chiappa S. and Brimijoin S. (1997) Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression. J. Neurochem. 69, 1389-1397.
28. Koenigsberger C., Hammond P. and Brimijoin S. (1998) Developmental expression of acetyl- and butyrylcholinesterase in the rat: enzyme and mRNA levels in embryonic dorsal root ganglia. Brain Res. 787, 248-258.
29. Lazar M., Salmeron E., Vigny M. and Massoulie J. (1984) Heavy isotope-labeling study of the metabolism of monomeric and tetrameric acetylcholinesterase forms in the murine neuronal-like T28 hybrid cell line. J. Biol. Chem. 259, 3703-3713.
30. Lorenzo A. and Yankner B. A. (1994) b-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247.
31. Mattson M. P. (1995) Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging 16, 447-457.
32. Moechars D. et al. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483-6492.
33. Mossman B. T. (1983) In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts. Environ. Health Perspect. 53, 155-161.
34. Nixon R. A., Cataldo A. M. and Mathews P. M. (2000) The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25, 1161-1172.
35. Oster-Granite M. L., McPhie D. L., Greenan J. and Neve R. L. (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16, 6732-6741.
36. Pike C., Walencewicz A., Glabe C. G. and Cotman C. (1991) Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367-368.
37. Pike C., Cummings B. and Cotman C. (1992) Beta-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3, 769-772.
38. Ray P. and Berman J. (1989) Prevention of muscarinic acetylcholine receptor down-regulation by chloroquine: antilysosomal or antimuscarinic mechanisms. Neurochem. Res. 14, 533-535.
39. Rees T., Hammond P., Soreq H., Younkin S. and Brimijoin S. (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging in press.
40. Rotundo R. L. (1983) Acetylcholinesterase biosynthesis and transport in tissue culture. Meth. Enzymol. 96, 353-367.
41. Rotundo R. L. (1988) Biogenesis of acetylcholinesterase molecular forms in muscle. Evidence for a rapidly turning over, catalytically inactive precursor pool. J. Biol. Chem. 263, 19398-19406.
42. Rotundo R. L. and Fambrough D. M. (1980) Synthesis, transport and fate of acetylcholinesterase in cultured chick embryos muscle cells. Cell 22, 583-594.
43. Sbarba P. D. and Rovida E. (2002) Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol. Chem. 383, 69-83.
44. Sbema G., Saez-Valero J., Beyreuther K., Masters C. L. and Small D. H. (1997) The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69, 1177-1184.
45. Sbema G., Saez-Valero J., Li Q. X., Czech C., Beyreuther K., Masters C. L., McLean C. A. and Small D. H. (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT 100) of the beta-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71, 723-731.
46. Schapira A. (1996) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9, 260-264.
47. Scharnagl H., Tisljar U., Winkler K., Huttinger M., Nauck M. A., Grob W., Wieland H., Ohm T. G. and Marz W. (1999) The bA4 amyloid peptide complexes to and enhances the uptake of b-very low density lipoprotein by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway. Lab. Invest. 79, 1271-1286.
48. Yang A. J., Chandswangbhuvana D., Margol L. and Glabe C. G. (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J. Neurosci. Res. 52, 691-698.
49. Yuan J. and Yankner B. A. (2000) Apoptosis in the nervous system. Nature 407, 802-809.